Archives: 7/2005

pistake Down the Drain with STDs
Via Gizmodo, news about a stylish new way of testing for STD’s:

Recently graduated designer Malcolm Kimberley has decided to take your health seriously. His Pistake Urinal takes samples of your urine, analyses them for sexually transmitted diseases, and sends the results to your cell phone via Bluetooth.

So much to say about this — first, we like the name of the urinal, which may entymologically refer to the pistachio shape of the sculpture (or, more likely, the method of providing a sample). It’s also a great idea to get medical results to people when it’s most relevant, especially if this is installed in clubs and bars.
Finally, we like the idea of bathrooms communicating with your phone — someday, toilets will send text message reminders when we forget to flush.
More from Malcolm Kimberly’s design site…

UPDATE:
Mr. Kimberly writes to inform us that the name of the installation is Relief, the working title was not changed in time for printing.

cand lister New DNA Tests on Tap to I.D. Bad MicrobesA new test from researchers at the Agricultural Research Service in Peoria, Illinois opens new diagnostic opportunities in infectious diseases:

Now, ARS scientists in Peoria, Illinois, have devised a new DNA-based approach for identifying these pathogens that’s faster, easier to use, and more precise than some currently used methods.
For example, pulsed-field gel electrophoresis (PFGE) is considered the gold standard for genetically identifying L. monocytogenes bacteria that cause food poisoning. But PFGE is difficult to run, takes about 3 days, and has several disadvantages that complicate efforts to determine the relationships between different isolates.
In contrast, “Our method can be performed in a single day,” says microbiologist Todd Ward, at ARS’s National Center for Agricultural Utilization Research, in Peoria, “and can target single nucleotide variations within specific genes…”
On the medical front, the test may enable hospital clinicians to cast a broader net for the 30 to 40 Candida species that can cause human infections, particularly in immunocompromised people. Page says the various culture-plate testing methods now used to diagnose Candida infection are limited to a few species–notably C. albicans–and the turnaround time is 24 hours to a few weeks, delaying treatment. Genetic fingerprinting tests used in some labs may be faster, but they too detect only a few Candida species.
By comparison, the test from Kurtzman’s unit identifies 32 total species–simultaneously and in less than 5 hours.
In a machine called a “flow cytometer,” which can handle up to 100 samples at a time, molecules called “probes” find and bind to corresponding pieces of species-specific DNA. The researchers created the probes using DNA-sequence information from their unit’s microbial-genomics database. The probes have a fluorescent marker that tells the cytometer which DNA sequence was detected. The machine clearly displays the species’ identity as color-coded bar graphs.

More

echo550 Now Hear This: LabCyte Acoustic Transferrance
All you pipette-heads out there, listen up: MIT’s Technology Review pointed us in the direction of Labcyte, an innovative new company looking to shrink the lab. One tool they’ve developed eliminates the need for cumbersome pipetting into those 96-well (or 384-well!) plates. Their technology actually uses ultrasound to move liquids around, without contact:

To keep down their costs during the drug discovery process, companies and universities are turning to miniaturization processes. But there’s a catch: standard lab equipment was not designed for dispensing tiny traces of substances. Labcyte has developed a proprietary technology for using focused acoustics, or ultrasound, to precisely transfer droplets down to 2.5 nanoliters. By transferring compounds directly into assay plates, the technology eliminates the need for tips, washing, and intermediate dilutions. Their system retails for around $225,000.
According to the company, six major pharmaceutical companies have purchased its systems, including GlaxoSmithKline and Astro Zeneca, as well as schools, including Vanderbilt University. Clients report improved results in the form of time savings, according to the company, which leads to a return on investment in the new equipment within about a year. Labcyte also expects to deploy its acoustic technologies for nano-dispensing liquids in the fields of genomics and proteomics.

More at Labcyte

We usually don’t post about public service announcements. This time we will make an exception.

Indiana University seeks volunteers with type 1 diabetes to participate in a clinical trial for inhaled insulin.
To qualify, participants must have had diabetes for at least 24 months and use at least two pre-meal insulin injections daily. Participants cannot be on an insulin pump, smoke, nor have asthma, COPD or cystic fibrosis.

Call 317-274-3948 for more info.
The press release

KingGeorgeIII The Madness of King GeorgeKing George the III presided over an important time in British history — 1760 to 1820. He kept the UK secure during the Napoleonic Wars. He lost the American colonies. And, on five occasions throughout his reign, he lost his mind.
Scholars have attributed the madness of King George to a hereditary disorder of heme synthesis, called porphyria. Heme is the important iron-carrying component of the hemoglobin protein, and its oxygenation gives blood its red color.
In fact, the complicated heme synthetic pathway can go wrong at a number of steps, and thus, there are at least seven kinds of porphyria. Each is a little different, but some of George’s family seems to be afflicted with variegate porphyria, due to a faulty protoporphyrin oxidase gene. During intermittent attacks, symptoms often included extreme skin sensitivity to sunlight, excessive hair growth, GI symptoms, seizures, and hallucinations.
(About twenty years ago, a fantastic notion was advanced: what if the vampires of European lore were porphyria victims? In addition to the sunlight-sensitivity thing, they had paleness, and a thirst for blood. This was taught to some of us in biochemistry class, but we weren’t given the straight dope.)
No one’s saying that George was a vampire (though the Colonials did ascribe to him some monstrous tendencies in the Declaration of Independence). But the severity and duration of his attacks seems excessive for porphyria.
heme The Madness of King GeorgeRecently, researchers writing in the Lancet offered an explanation:

We report the analysis of hair obtained from George III. Although no genomic DNA could be obtained, metal analysis revealed high concentrations of arsenic. Since arsenic interferes with haem metabolism, it might have contributed to the King’s unusually severe and prolonged bouts of illness. We have identified sources of arsenic in the context of the medication George III received from physicians.

The sources of arsenic were described in the paper, and in the news:

…there is little information available to account for the unusual persistence, severity, and late onset of attacks. One possible explanation is exposure to heavy metals, including lead and mercury.
Martin Warren (University of Kent, UK) and colleagues … found that the principal compound administered to the King during his illness was emetic tartar. Emetic tartar contains a substance called antimony, which can be contaminated with arsenic.
The authors believe that the King’s medication was the source of the arsenic found in the hair sample.
Professor Warren states: “The presence of arsenic in a sample of the King’s hair provides a plausible explanation for the length and severity of his attacks of illness; and contamination of his antimonial medications is the probable source of the arsenic. We propose that exposure to arsenic would exacerbate attacks of porphyria in a genetically predisposed individual.”

So, the doctors’ therapy worsened the King’s condition. Of course, there are other instances of leaders brought down by health authorities in history.
 The Madness of King GeorgeIn 1994, a movie about King George’s bouts with madness was released. In the UK, it was called “The Madness of George III”. There’s a persistent rumor that the US title was changed to “The Madness of King George”, in part because Americans might mistake the “III” as referring to a sequel or nonexistent trilogy.
We think that’s exactly the kind of hubris that led to the Revolution. Will the British ever stop underestimating us? It’s obvious that this movie occurs in the middle of a series, and the prequels haven’t been made yet.
That’s all for this week. Enjoy the weekend and see you Monday!

chemo nano mit MIT Creates Chemotherapy Loaded NanoparticlesThe new nanoparticle specifically targets neoplastic cells with double action:

The dual-chamber, double-acting, drug-packing “nanocell” proved effective and safe, with prolonged survival, against two distinct forms of cancers-melanoma and Lewis lung cancer-in mice.
The work will be reported in the July 28 issue of Nature, with an accompanying commentary.
“We brought together three elements: cancer biology, pharmacology and engineering,” said Ram Sasisekharan, a professor in MIT’s Biological Engineering Division and leader of the research team.
“The fundamental challenges in cancer chemotherapy are its toxicity to healthy cells and drug resistance by cancer cells,” Sasisekharan said. “So cancer researchers were excited about anti-angiogenesis,” the theory that cutting off the blood supply can starve tumors to death. That strategy can backfire, however, because it also starves tumor cells of oxygen, prompting them to create new blood vessels and instigate metastasis and other self-survival activities.
The next obvious solution would be combining chemotherapy and anti-angiogenesis-dropping the bombs while cutting the supply lines. But combination therapy confronted an inherent engineering problem. “You can’t deliver chemotherapy to tumors if you have destroyed the vessels that take it there,” Sasisekharan said. Also, the two drugs behave differently and are delivered on different schedules: anti-angiogenics over a prolonged period and chemotherapy in cycles.
“We designed the nanocell keeping these practical problems in mind,” he said. Using ready-made drugs and materials, “we created a balloon within a balloon, resembling an actual cell,” explains Shiladitya Sengupta, a postdoctoral associate in Sasisekharan’s laboratory…
The team loaded the outer membrane of the nanocell with an anti-angiogenic drug and the inner balloon with chemotherapy agents. A “stealth” surface chemistry allows the nanocells to evade the immune system, while their size (200 nanometers) makes them preferentially taken into the tumor. They are small enough to pass through tumor vessels, but too large for the pores of normal vessels.
Once the nanocell is inside the tumor, its outer membrane disintegrates, rapidly deploying the anti-angiogenic drug. The blood vessels feeding the tumor then collapse, trapping the loaded nanoparticle in the tumor, where it slowly releases the chemotherapy.
The team tested this model in mice. The double-loaded nanocell shrank the tumor, stopped angiogenesis and avoided systemic toxicity much better than other treatment and delivery variations.

More at MIT News Office…

blogdepression Blog Depression Pamphlet Is HereThe NONIST believes that there is a growing epidemic:

there is a growing epidemic in the cyberworld. a scourge which causes more suffering with each passing day. as blogging has exploded and, under the stewardship of the veterans, the form has matured more and more bloggers are finding themselves disillusioned, dissatisfied, taking long breaks, and in many cases simply closing up shop. this debilitating scourge ebbs and flows but there is hardly a blogger among us who has not felt it’s dark touch. we’re speaking, of course, about blog depression.

Pamphlet website (press on Read More)…
(hat tip: Textually.org)

Echinacea takes a beating in a large study published in the NEJM.
More at the New York Times
The abstract

8tdaze sm 8T DAZE of Compliance8TDAZE is the mobile SMS compliance program, created by PediaMed–The Pediatrics Company™, for Allergan’s TAZORAC® (Tazarotene) Cream 0.1%. The TAZORAC®, a topical retinoid indicated for the treatment of acne vulgaris, requires good compliance among patients in order to achieve the best results. Hence the 8T DAZE for teens:

For the best results when treating acne with TAZORAC® Cream 0.1%, use the product as directed by your doctor. You should start to see results in just 4 weeks, but for best results, stick with it for about 80 days. While 80 days may seem like a long time at first, it’s not so bad when you think about having only one face for the rest of your life, right?
So…to help you through the 80 days, we decided to help you out with 8T DAZE — where TAZORAC® Cream 0.1% users like you can receive free ringtones and wallpapers for your cell phone.
Just pick out a member from the T Crew (T for TAZORAC®) and they’ll send you a text every other week or so for the next 80 days. Your text message will tell you how to download your free ringtone or wallpaper.

R U READY 4 UR 8T DAZE?
8T DAZE press release
(hat tip: Textually.org)